ImmuCell Corporation
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 38.8% | 45.0% | 39.3% | 47.3% | 53.3% | 61.3% | 52.8% | 50.7% | 55.8% | 52.5% | 50.1% | 53.9% | 51.1% | 49.4% | 54.5% | 56.7% | 53.7% | 56.7% | 61.0% | 54.3% | 53.0% | 53.0% | 48.3% | 55.8% | 61.5% | 59.6% | 91.3% | 70.5% | 76.5% | 75.3% | 68.4% | 77.5% | 73.7% | 63.5% | 58.4% | 56.3% | 57.1% | 61.8% | 55.0% | 66.1% | 59.7% | |
| 61.2% | 55.0% | 60.7% | 52.7% | 46.7% | 38.7% | 47.2% | 49.3% | 44.2% | 47.5% | 49.9% | 46.1% | 48.9% | 50.6% | 45.5% | 43.3% | 46.3% | 43.3% | 39.0% | 45.7% | 47.0% | 47.0% | 51.7% | 44.2% | 38.5% | 40.4% | 8.7% | 29.5% | 23.5% | 24.7% | 31.6% | 22.5% | 26.3% | 36.5% | 41.6% | 43.7% | 42.9% | 38.2% | 45.0% | 33.9% | 40.3% | |
| 15.6% | 11.5% | 9.6% | 22.1% | 29.2% | 23.4% | 20.2% | 25.3% | 42.2% | 43.0% | 20.6% | 30.3% | 33.2% | 26.8% | 19.8% | 36.6% | 30.2% | 31.3% | 25.1% | 22.0% | 20.3% | 20.0% | 17.3% | 29.5% | 26.5% | 26.8% | 32.2% | 31.1% | 20.7% | 20.9% | 17.4% | 18.8% | 13.1% | 10.6% | 9.4% | 12.9% | 12.6% | 10.0% | 3.1% | 1.7% | 6.2% | |
| 18.4% | 17.1% | 10.7% | 22.8% | 19.2% | 11.5% | 14.7% | 14.7% | 18.4% | 16.2% | 9.5% | 16.7% | 13.4% | 11.5% | 9.8% | 14.2% | 10.5% | 11.3% | 10.4% | 9.3% | 8.6% | 8.0% | 11.4% | 13.7% | 9.7% | 14.9% | 16.5% | 15.0% | 9.5% | 23.4% | 7.3% | 11.0% | 8.8% | 7.2% | 18.3% | 11.2% | 13.2% | 14.8% | 11.0% | 17.7% | 13.9% | |
| 58.6% | 49.7% | 34.8% | 67.8% | 70.7% | 51.9% | 53.4% | 55.7% | 83.6% | 79.1% | 43.9% | 66.3% | 63.3% | 57.3% | 41.5% | 66.6% | 53.0% | 60.2% | 48.1% | 40.9% | 41.7% | 44.4% | 42.2% | 60.2% | 51.4% | 82.2% | 74.2% | 66.5% | 45.4% | 44.4% | 35.8% | 47.8% | 35.9% | 28.5% | 86.1% | 34.9% | 42.6% | 38.9% | 26.0% | 7.0% | 27.7% | |
| 2.6% | 5.4% | 25.9% | -15.2% | -24.1% | -13.2% | -6.2% | -6.4% | -6.9% | -31.5% | 6.0% | -20.2% | -14.5% | -6.7% | 4.0% | -23.3% | -6.8% | -16.9% | -9.1% | 4.7% | 5.3% | 2.7% | 9.5% | -16.0% | -12.9% | -41.8% | -65.5% | -36.9% | -21.9% | -19.7% | -4.1% | -25.3% | -9.6% | 8.0% | 13.9% | 8.8% | 0.4% | -0.8% | 19.0% | 26.9% | 12.6% | |
| 2.1% | 2.3% | 1.1% | 2.5% | 2.7% | 2.6% | 3.3% | 3.5% | 5.1% | 3.9% | 2.6% | 4.1% | 3.6% | 2.7% | 3.7% | 2.6% | 2.0% | 2.3% | 1.9% | 1.7% | 1.5% | 1.4% | 1.3% | 2.3% | 1.9% | 2.4% | 2.6% | 2.5% | 2.7% | 3.2% | 2.0% | 2.6% | 2.2% | 1.6% | 1.5% | 1.9% | 2.4% | 1.4% | 1.0% | 1.3% | 1.4% | |
| 1.2% | 3.1% | 25.1% | -17.2% | -26.5% | -15.7% | -9.4% | -9.8% | -11.9% | -35.3% | 3.5% | -22.6% | -16.7% | -8.6% | -2.8% | -25.8% | -8.7% | 5.2% | -10.7% | 3.1% | 3.0% | 1.4% | 8.6% | -17.7% | -13.6% | -42.6% | -67.1% | -39.0% | -17.4% | -22.3% | -6.0% | -28.0% | -11.7% | 6.7% | 18.0% | 7.8% | -2.5% | -37.3% | 18.9% | 26.2% | 2.8% | |
| -0.6% | 1.7% | 8.6% | -4.8% | -9.6% | -9.5% | -1.7% | 16.6% | -0.3% | 0.5% | 0.2% | 0.6% | 0.3% | -0.1% | -0.3% | 0.1% | 0.1% | 0.1% | 1.9% | 0.1% | 0.2% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.1% | 0.0% | 0.1% | 0.6% | 0.2% | |
| 1.8% | 1.4% | 16.5% | -12.5% | -16.9% | -6.2% | -7.7% | -26.5% | -11.6% | -35.8% | 3.3% | -23.1% | -16.9% | -8.5% | -2.5% | -25.8% | -8.7% | 5.0% | -10.7% | 3.1% | 2.9% | 1.4% | 8.6% | -17.7% | -13.7% | -42.6% | -67.2% | -39.1% | -17.4% | -22.4% | -6.0% | -28.0% | -11.7% | 6.6% | 17.9% | 7.8% | -2.5% | -37.4% | 18.7% | 25.5% | 2.6% | |
| 12.8% | 14.4% | 32.1% | -2.6% | -13.4% | -4.7% | 3.8% | 3.2% | 11.0% | -12.1% | 19.0% | 2.6% | 6.0% | 9.5% | 15.7% | -3.9% | 9.5% | 19.2% | 6.3% | 18.6% | 16.6% | 13.9% | 20.2% | 0.9% | 1.4% | -11.3% | -45.2% | -16.5% | -1.8% | -6.2% | 5.2% | -13.1% | 1.7% | 17.0% | 22.2% | 20.1% | 9.9% | -26.7% | 24.9% | 34.1% | 11.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.